Mackay Shields LLC’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-127,799
Closed -$465K 1527
2019
Q4
$465K Sell
127,799
-16,300
-11% -$132K ﹤0.01% 1173
2019
Q3
$1.2M Buy
144,099
+20,500
+17% +$166K 0.01% 1073
2019
Q2
$1.06M Buy
123,599
+84,897
+219% +$759K 0.01% 1107
2019
Q1
$413K Buy
38,702
+4,800
+14% +$51.4K ﹤0.01% 1220
2018
Q4
$297K Sell
33,902
-2,595
-7% -$33.1K ﹤0.01% 1250
2018
Q3
$613K Buy
36,497
+2,400
+7% +$51.9K ﹤0.01% 972
2018
Q2
$715K Hold
34,097
0.01% 1028
2018
Q1
$549K Buy
+34,097
New +$675K ﹤0.01% 1100

Other funds holding SPPI

Mackay Shields LLC's SPPI Position: Q1 2020 in Review

Mackay Shields LLC sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 127,799 shares — an estimated $465K sold.

Mackay Shields LLC first reported a position in SPPI in Q1 2018 and held it in 8 quarters. The position peaked at $1.2M in Q3 2019. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Mackay Shields LLC reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 127,799 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $465K.
  • Mackay Shields LLC first reported a position in Spectrum Pharmaceuticals Inc in Q1 2018 and held it in 8 quarters.
  • Mackay Shields LLC's Spectrum Pharmaceuticals Inc position peaked at $1.2M in Q3 2019.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Mackay Shields LLC's 13F filing for Q1 2020, filed 8 May 2020.